Fate Therapeutics Reports Third Quarter 2019 Financial Results and Highlights Operational Progress

Go back to Fate Therapeutics Reports Third Quarter 2019 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.29 -0.03 (1.29%)
Previous Close $2.32    52 Week High $4.76 
Open $2.33    52 Week Low $1.46 
Day High $2.38    P/E N/A 
Day Low $2.26    EPS $-1.91 
Volume 423,322